SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-009134
Filing Date
2023-05-10
Accepted
2023-05-10 16:30:58
Documents
66
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q iova-20230331x10q.htm   iXBRL 10-Q 1771831
2 EX-31.1 iova-20230331xex31d1.htm EX-31.1 12336
3 EX-31.2 iova-20230331xex31d2.htm EX-31.2 12223
4 EX-32.1 iova-20230331xex32d1.htm EX-32.1 7091
5 EX-32.2 iova-20230331xex32d2.htm EX-32.2 7164
6 GRAPHIC iova-20230331x10q001.jpg GRAPHIC 79986
  Complete submission text file 0001558370-23-009134.txt   7293236

Data Files

Seq Description Document Type Size
7 EX-101.SCH iova-20230331.xsd EX-101.SCH 46283
8 EX-101.CAL iova-20230331_cal.xml EX-101.CAL 45479
9 EX-101.DEF iova-20230331_def.xml EX-101.DEF 221563
10 EX-101.LAB iova-20230331_lab.xml EX-101.LAB 351038
11 EX-101.PRE iova-20230331_pre.xml EX-101.PRE 320190
60 EXTRACTED XBRL INSTANCE DOCUMENT iova-20230331x10q_htm.xml XML 1251170
Mailing Address 825 INDUSTRIAL ROAD 4TH FLOOR SAN CARLOS CA 94070
Business Address 825 INDUSTRIAL ROAD 4TH FLOOR SAN CARLOS CA 94070 6502607120
IOVANCE BIOTHERAPEUTICS, INC. (Filer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36860 | Film No.: 23907014
SIC: 2836 Biological Products, (No Diagnostic Substances)